COFCO Biotechnology Co., Ltd. (SHE:000930)

COFCO Biotechnology Revenue

COFCO Biotechnology had revenue of 3.88B CNY in the quarter ending March 31, 2026, a decrease of -11.55%. This brings the company's revenue in the last twelve months to 17.01B, down -13.71% year-over-year. In the year 2025, COFCO Biotechnology had annual revenue of 17.51B, down -12.67%.

• Revenue (ttm): 17.01B
• Revenue Growth: -13.71%
• P/S Ratio: 0.66
• Revenue / Employee: 3.23M
• Employees: 5,261
• Market Cap: 11.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.51B	-2.54B	-12.67%
Dec 31, 2024	20.05B	-325.59M	-1.60%
Dec 31, 2023	20.38B	460.90M	2.31%
Jan 1, 2023	19.92B	-3.64B	-15.46%
Jan 1, 2022	23.56B	3.65B	18.33%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error